Selecting antimicrobial therapy for suspected infection in critically ill patients is an important decision-making process for intensivists. In this current age of multi-drug-resistant organisms (MDROs), intensivists must balance the increased mortality associated with delaying therapy of microbiologically documented infections with the potential ecological damage caused by antimicrobial medications, including the selection and development of MDROs

Read More